INanoBio CEO, Bharath Takulapalli will be presenting at the Precision Medicine World Conference 2022 at the Santa Clara Convention Center.
INanoBio CEO, Bharath Takulapalli to speak at the MEMS & Sensors Technical Congress to be held at the David Brower Center in Berkeley.
Nanopore Sequencing Firm iNanoBio Says Fast Sensor Will Result in Speedy Platform
INanoBio Announces Successful Development of Novel Nanopore Transistor Prototype, a Step Towards Ultra-Fast DNA Sequencing
INanoBio Nabs $5.4M From DARPA for Silicon Nanopore Sequencer Development
INanoBio awarded up to $5.4 Million to develop an Epigenetic Sequencer under the DARPA ECHO Program.
Dr. Abhay Sanan and JP Million join INanoBio Board of Directors as part of 2018 Series Seed financing
INanoBio awarded $0.7 M grant by National Institute of Health (NIH) to develop an advanced automated system for high throughput proteomic assays.
INanoBio CEO Bharath Takulapalli to Keynote IEEE VLSI TSA conference in Taiwan.
INanoBio participates in Nature.com webcast on ‘Advances in Precision Medicine and Genomic Sequencing’.
Prof. Chenming Hu, inventor of FINFET or 3D transistor & Microelectronics Visionary has joined INanoBio’s Scientific Advisory Board.
Genomics pioneer Prof. George Church of Harvard Medical School will chair INanoBio’s Scientific Advisory Board.
Former CEO of PCS Health JP Millon, who is currently on the Board of CVS Health has joined INanoBio’s Advisory Board.